Todo H - Search Results

1

Controlled release of a model hydrophilic high molecular weight compound from injectable non-lamellar liquid crystal formulations containing different types of phospholipids.

Okada A, Todo H, Hijikuro I, Itakura S, Sugibayashi K. Okada A, et al. Among authors: todo h. Int J Pharm. 2020 Mar 15;577:118944. doi: 10.1016/j.ijpharm.2019.118944. Epub 2019 Dec 21. Int J Pharm. 2020. PMID: 31870952

2

Effects of pretreatment of needle puncture and sandpaper abrasion on the in vitro skin permeation of fluorescein isothiocyanate (FITC)-dextran.

Wu XM, Todo H, Sugibayashi K. Wu XM, et al. Among authors: todo h. Int J Pharm. 2006 Jun 19;316(1-2):102-8. doi: 10.1016/j.ijpharm.2006.02.046. Epub 2006 Apr 4. Int J Pharm. 2006. PMID: 16597490

3

Conversion of FAD to FMN and riboflavin in plasma: effects of measuring method.

Akimoto M, Sato Y, Okubo T, Todo H, Hasegawa T, Sugibayashi K. Akimoto M, et al. Among authors: todo h. Biol Pharm Bull. 2006 Aug;29(8):1779-82. doi: 10.1248/bpb.29.1779. Biol Pharm Bull. 2006. PMID: 16880644 Free article.

4

Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis.

Wu XM, Todo H, Sugibayashi K. Wu XM, et al. Among authors: todo h. J Control Release. 2007 Apr 2;118(2):189-95. doi: 10.1016/j.jconrel.2006.12.017. Epub 2006 Dec 23. J Control Release. 2007. PMID: 17270306

5

Dermatopharmacokinetics of salicylate following topical injection in rats: effect of osmotic pressure and injection volume on salicylate disposition.

Yoshida D, Todo H, Hasegawa T, Sugibayashi K. Yoshida D, et al. Among authors: todo h. Int J Pharm. 2007 Jun 7;337(1-2):142-7. doi: 10.1016/j.ijpharm.2006.12.040. Epub 2007 Jan 7. Int J Pharm. 2007. PMID: 17280809

6

Preparation and evaluation of gene-transfected cultured skin as a novel drug delivery system for severely burned skin.

Hada N, Todo H, Komada F, Sugibayashi K. Hada N, et al. Among authors: todo h. Pharm Res. 2007 Aug;24(8):1473-9. doi: 10.1007/s11095-007-9265-9. Epub 2007 Mar 22. Pharm Res. 2007. PMID: 17377741

7

Analysis of skin disposition of flurbiprofen after topical application using dual agar gel discs-inserted rats.

Hasegawa T, Kawazome A, Yanagimoto G, Hayashi T, Seki T, Akimoto M, Todo H, Sugibayashi K. Hasegawa T, et al. Among authors: todo h. Biol Pharm Bull. 2007 Nov;30(11):2135-40. doi: 10.1248/bpb.30.2135. Biol Pharm Bull. 2007. PMID: 17978488 Free article.

8

Pretreatment effects of moxibustion on the skin permeation of FITC-dextran.

Cao D, Kitamura T, Todo H, Yoo SD, Sugibayashi K. Cao D, et al. Among authors: todo h. Int J Pharm. 2008 Apr 16;354(1-2):117-25. doi: 10.1016/j.ijpharm.2007.11.003. Epub 2007 Nov 9. Int J Pharm. 2008. PMID: 18079074

9

Analysis of skin disposition and metabolism of ethyl nicotinate after topical application using dual agar gel disc-inserted rats.

Hasegawa T, Kawazome A, Matsumoto K, Yanagimoto G, Hayashi T, Akimoto M, Todo H, Sugibayashi K. Hasegawa T, et al. Among authors: todo h. Biol Pharm Bull. 2008 Jan;31(1):85-9. doi: 10.1248/bpb.31.85. Biol Pharm Bull. 2008. PMID: 18175947 Free article.

10

Effect of vasoactive agents on the dermatopharmacokinetics and systemic disposition of model compounds, salicylate and FITC-dextran 4 kDa, following intracutaneous injection of the compounds.

Yoshida D, Todo H, Hasegawa T, Sugibayashi K. Yoshida D, et al. Among authors: todo h. Int J Pharm. 2008 May 22;356(1-2):181-6. doi: 10.1016/j.ijpharm.2008.01.005. Epub 2008 Jan 12. Int J Pharm. 2008. PMID: 18294788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters